To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.
Publication
, Journal Article
Lowenstern, A; Newby, LK
Published in: J Am Heart Assoc
September 22, 2017
Duke Scholars
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
September 22, 2017
Volume
6
Issue
9
Location
England
Related Subject Headings
- Registries
- Purinergic P2Y Receptor Antagonists
- Non-ST Elevated Myocardial Infarction
- Humans
- Coronary Artery Bypass
- Cardiac Catheterization
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lowenstern, A., & Newby, L. K. (2017). To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question. J Am Heart Assoc, 6(9). https://doi.org/10.1161/JAHA.117.007288
Lowenstern, Angela, and L Kristin Newby. “To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.” J Am Heart Assoc 6, no. 9 (September 22, 2017). https://doi.org/10.1161/JAHA.117.007288.
Lowenstern A, Newby LK. To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question. J Am Heart Assoc. 2017 Sep 22;6(9).
Lowenstern, Angela, and L. Kristin Newby. “To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.” J Am Heart Assoc, vol. 6, no. 9, Sept. 2017. Pubmed, doi:10.1161/JAHA.117.007288.
Lowenstern A, Newby LK. To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question. J Am Heart Assoc. 2017 Sep 22;6(9).
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
September 22, 2017
Volume
6
Issue
9
Location
England
Related Subject Headings
- Registries
- Purinergic P2Y Receptor Antagonists
- Non-ST Elevated Myocardial Infarction
- Humans
- Coronary Artery Bypass
- Cardiac Catheterization
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology